Noberastine
Alternative Names: R 64947Latest Information Update: 01 Jul 1998
At a glance
- Originator Cilag AG
- Class Antiallergics; Antiasthmatics; Antihistamines; Imidazoles; Pyridines; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Allergic rhinitis; Asthma
Most Recent Events
- 01 Jul 1998 No-Development-Reported for Allergic rhinitis in Belgium (PO)
- 01 Jul 1998 No-Development-Reported for Allergic rhinitis in USA (PO)
- 01 Jul 1998 No-Development-Reported for Asthma in Belgium (PO)